@ARTICLE{
author={Verschraegen Claire|,Andric Zoran G|0000-0002-1495-2729,Moiseenko Fedor|,Makharadze Tamta|,Shevnya Sergii|,Oleksiienko Alona|,Ruiz Eduardo Yanez|,Kim SungHyun|,Ahn KeumYoung|,Park TaeHong|,Park Sijin|,Ju Hana|,Ohe Yuichiro|},
year={2022},
title={Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial},
journal={BIODRUGS},
volume={36},
number={6},
pages={749-760},
document_type={Article},
}